Skip to main content
. 2019 Jul 2;11(1):151–161. doi: 10.1111/jdi.13092

Figure 1.

Figure 1

Proportion of newly diagnosed type 2 diabetes patients reaching the target of glycated hemoglobin A1c <7.0% under hypoglycemic treatment patterns at baseline and during the 12 months of follow up. OADs, oral antidiabetic drugs.